|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02616 CSTONE PHARMA-B
Nominal 
2.760 +0.250 (+9.960%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 93,218 | -11.779% | 105,664 | 138,379 | 154,166 | 39,367 |
| Land & other Lease Assets | 37,325 | -21.757% | 47,704 | 68,187 | 28,631 | 27,175 |
| Intangible Assets | 161,366 | -6.749% | 173,045 | 159,699 | 70,539 | 6,509 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 11,649 | 100.879% | 5,799 | 25,245 | 60,472 | 117,398 |
| 303,558 | -8.625% | 332,212 | 391,510 | 313,808 | 190,449 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 286,096 | 162.888% | 108,828 | 22,188 | 61,363 | 0 | |
| Trade Receivables | 83,929 | -51.328% | 172,438 | 77,133 | 117,598 | 0 | |
| Cash & Bank Balances | 387,937 | -61.077% | 996,671 | 558,684 | 742,724 | 3,024,548 | |
| Other Current Assets | 331,946 | 540.204% | 51,850 | 588,912 | 1,035,960 | 547,755 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 1,089,908 | -18.039% | 1,329,787 | 1,246,917 | 1,957,645 | 3,572,303 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 338,029 | 37.200% | 246,377 | 290,414 | 414,293 | 28,030 | ||
| S-T Debt & Leases | 93,216 | -33.089% | 139,313 | 44,918 | 43,948 | 11,314 | ||
| Other Current Liabilities | 250,761 | -46.032% | 464,648 | 611,150 | 474,707 | 687,705 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 682,006 | -19.796% | 850,338 | 946,482 | 932,948 | 727,049 | |||
| Net Current Assets | 407,902 | -14.923% | 479,449 | 300,435 | 1,024,697 | 2,845,254 | ||
| Total Assets Less Current Liabilities | 711,460 | -12.345% | 811,661 | 691,945 | 1,338,505 | 3,035,703 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 262,757 | 17.232% | 224,135 | 241,372 | 130,250 | 72,545 | |||
| Other Non-current Liabilities | 84,832 | -35.092% | 130,696 | 1,247 | 1,247 | 8,698 | |||
| 347,589 | -2.041% | 354,831 | 242,619 | 131,497 | 81,243 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 860 | 0.000% | 860 | 802 | 796 | 787 | ||||
| Reserves | 363,011 | -20.387% | 455,970 | 448,524 | 1,206,212 | 2,953,673 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 363,871 | -20.349% | 456,830 | 449,326 | 1,207,008 | 2,954,460 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 363,871 | -20.349% | 456,830 | 449,326 | 1,207,008 | 2,954,460 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 0 | 34,690 | 82,269 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -91,207,000 |
| %Change | -75.164% |
| EPS / (LPS) | RMB -0.070 |
| NBV Per Share (¥) | RMB 0.283 |